Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· February 11, 2026

Stocks Settle Mixed as Fed Rate Cut Chances Slip

View original at nasdaq.com
Stocks Settle Mixed as Fed Rate Cut Chances Slip The S&P 500 Index ($SPX) (SPY) closed unchanged on Wednesday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.13%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.29%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q1 revenue forecast of $158 million to $172 million

    80% confidence
  • Full-year Ebitda margin forecast of 18% to 19%

    80% confidence
  • Further rate cuts risk allowing high inflation to persist even longer

    80% confidence
  • Q4 earnings excluding Magnificent Seven expected to increase by +4.6%

    80% confidence
  • Full-year adjusted EPS forecast of $2.55 to $2.65

    80% confidence
  • Fed should hold rates at a somewhat restrictive level

    80% confidence
  • Full-year adjusted EPS forecast of $1.18 to $1.30

    80% confidence
  • S&P earnings growth is expected to climb by +8.4% in Q4

    80% confidence
  • Full-year revenue forecast of $835 million to $843 million

    80% confidence
  • Full-year revenue forecast of $2.79 billion to $2.80 billion

    80% confidence
  • Full-year net sales forecast of $13.25 billion to $13.75 billion

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com